<!DOCTYPE html>
<html lang="en" dir="ltr" prefix="content: http://purl.org/rss/1.0/modules/content/  dc: http://purl.org/dc/terms/  foaf: http://xmlns.com/foaf/0.1/  og: http://ogp.me/ns#  rdfs: http://www.w3.org/2000/01/rdf-schema#  schema: http://schema.org/  sioc: http://rdfs.org/sioc/ns#  sioct: http://rdfs.org/sioc/types#  skos: http://www.w3.org/2004/02/skos/core#  xsd: http://www.w3.org/2001/XMLSchema# ">
<head>
    <meta charset="utf-8" />
<script>(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","https://www.google-analytics.com/analytics.js","ga");ga("create", "UA-2231938-8", {"cookieDomain":"auto"});ga("require", "linkid", "linkid.js");ga("set", "anonymizeIp", true);ga("send", "pageview");</script>
<meta name="Generator" content="Drupal 8 (https://www.drupal.org)" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Merriweather:300|Lato:italic,700|Josefin+Sans:700,300&amp;subset=latin,latin-ext" media="all" />
<link rel="shortcut icon" href="/insureintell-1col/core/misc/favicon.ico" type="image/vnd.microsoft.icon" />
<link rel="canonical" href="/insureintell-1col/taxonomy/term/43" />
<link rel="shortlink" href="/insureintell-1col/taxonomy/term/43" />
<link rel="delete-form" href="/insureintell-1col/taxonomy/term/43/delete" />
<link rel="edit-form" href="/insureintell-1col/taxonomy/term/43/edit" />
<link rel="display" href="/insureintell-1col/taxonomy/term/43/manage-display" />
<link rel="alternate" type="application/rss+xml" title="NT-proBNP" href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/43/feed" />

        <title>NT-proBNP | Insureintell.com</title>
        <link rel="stylesheet" media="all" href="/insureintell-1col/sites/default/files/css/css_EM7WZGSOXJKTK2E_qJAyBfceGhIB9FIdCRBVbGwvNLg.css" />
<link rel="stylesheet" media="all" href="/insureintell-1col/sites/default/files/css/css_1g_7Rhof1xPNoR5sXcW2q6l4KX3RXBNPK2sTAkysEdQ.css" />

            
<!--[if lte IE 8]>
<script src="/insureintell-1col/sites/default/files/js/js_VtafjXmRvoUgAzqzYTA3Wrjkx9wcWhjP0G4ZnnqRamA.js"></script>
<![endif]-->

     <link href='//fonts.googleapis.com/css?family=Raleway:400,300,600' rel='stylesheet' type='text/css'>

                  </head>
<body class="fontyourface path-taxonomy">
<a href="#main-content" class="visually-hidden focusable skip-link">
    Skip to main content
</a>

  <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
    
<div id="page-wrapper">
    <div id="page">
        <header id="header" class="header" role="banner" aria-label="Site header">
            <div class="section clearfix">
                
                <div class="no-mobile">  <div>
    <div id="block-iiiii-3" class="block block-block-content block-block-content44d5b48e-4a9b-4767-974f-db75c458b064">
    
        
            <div class="content">
            
            <div><table align="center" border="0" cellpadding="1" cellspacing="1" style="width: 60%;">
	<tbody>
		<tr>
			<td style="width: 100%;">
			<h1 class="text-align-center"><a href="/">Insureintell.com</a></h1>

			<p class="text-align-center"><a href="https://www.hannover-re.com"><img alt="" height="30" src="/sites/site.dd/files/2020-06/HannoverRe_0.svg" width="160" /></a>&nbsp; &nbsp;<a href="http://www.rxhistories.com"><img alt="" height="48" src="/sites/site.dd/files/2020-06/Milliman-1_0.svg" width="119" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.scor.com"><img alt="rag" height="43" src="/sites/site.dd/files/2020-06/Logo-SCOR-The-Art-2_0.svg" width="153" /></a>&nbsp;&nbsp;&nbsp;<a href="http://www.rgare.com"><img alt="" height="42" src="/sites/site.dd/files/2020-06/RGA_0.svg" width="117" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.canadalife.com"><img alt="" height="45" src="/sites/site.dd/files/2020-06/CanLife_Blue_0.svg" width="178" /></a></p>

	
			</td>
		</tr>
		<tr>
			<td class="text-align-center" style="width: 100%;">
			<h4><a href="/news">News</a>&nbsp;-&nbsp;<a href="/articles/">Articles</a>&nbsp;-&nbsp;<a href="/newsletter">Newsletter</a>&nbsp;-&nbsp;<a href="/contact">Contact</a>&nbsp;- <a href="/hot-notes">Hot Notes</a></h4>
			</td>
		</tr>
	</tbody>
</table>
</div>
      
        </div>
    </div>

  </div>
</div>
                <nav id="navigation" class="navbar replaceme menu original">
                <div class="menu-header">  <div>
    <div id="block-iiiii-3" class="block block-block-content block-block-content44d5b48e-4a9b-4767-974f-db75c458b064">
    
        
            <div class="content">
            
            <div><table align="center" border="0" cellpadding="1" cellspacing="1" style="width: 60%;">
	<tbody>
		<tr>
			<td style="width: 100%;">
			<h1 class="text-align-center"><a href="/">Insureintell.com</a></h1>

			<p class="text-align-center"><a href="https://www.hannover-re.com"><img alt="" height="30" src="/sites/site.dd/files/2020-06/HannoverRe_0.svg" width="160" /></a>&nbsp; &nbsp;<a href="http://www.rxhistories.com"><img alt="" height="48" src="/sites/site.dd/files/2020-06/Milliman-1_0.svg" width="119" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.scor.com"><img alt="rag" height="43" src="/sites/site.dd/files/2020-06/Logo-SCOR-The-Art-2_0.svg" width="153" /></a>&nbsp;&nbsp;&nbsp;<a href="http://www.rgare.com"><img alt="" height="42" src="/sites/site.dd/files/2020-06/RGA_0.svg" width="117" /></a>&nbsp;&nbsp;&nbsp;<a href="https://www.canadalife.com"><img alt="" height="45" src="/sites/site.dd/files/2020-06/CanLife_Blue_0.svg" width="178" /></a></p>

	
			</td>
		</tr>
		<tr>
			<td class="text-align-center" style="width: 100%;">
			<h4><a href="/news">News</a>&nbsp;-&nbsp;<a href="/articles/">Articles</a>&nbsp;-&nbsp;<a href="/newsletter">Newsletter</a>&nbsp;-&nbsp;<a href="/contact">Contact</a>&nbsp;- <a href="/hot-notes">Hot Notes</a></h4>
			</td>
		</tr>
	</tbody>
</table>
</div>
      
        </div>
    </div>

  </div>
 &nbsp; <div id="nav-icon"><span></span><span></span><span></span><span></span><span></span><span></span></div></div>
                    <div class="container">
                    
                    </div>
                </nav>
            </div>
        </header>
                    <div class="highlighted">
                <aside class="section clearfix" role="complementary">
                      <div>
    <div data-drupal-messages-fallback class="hidden"></div>

  </div>

                </aside>
            </div>
                        <div id="main-wrapper" class=" clearfix">
            <div id="main" class="clearfix">
                
                                                    <section class="section">
                        <a id="main-content" tabindex="-1"></a>
                                                                            
                        <div class="ten">
                              <div>
    <div id="block-light-skeleton-page-title" class="block block-core block-page-title-block">
    
        
            <div class="content">
            
<div class="sixteen page-title container floated ">
    <h1 class="title_page" >NT-proBNP</h2>
</div>


        </div>
    </div>
<section class="page-content container floated ">
<div class="views-element-container"><div class="js-view-dom-id-758ad26c116fe776de9b87aff5e83136098e1661678ac4b590c9192c475e7ebd">
  
  
  

      <header>
      <div about="/insureintell-1col/taxonomy/term/43" typeof="schema:Thing">
  
      <span property="schema:name" content="NT-proBNP" class="hidden"></span>

  
</div>

    </header>
  
  
  

      <div class="views-row"><article data-history-node-id="25932" role="article" about="/node/25932">

  
      <h2>
      <a href="/node/25932" rel="bookmark"><span>Demystifying NT-proBNP as a Screening Marker for Underwriting Purposes </span>
</a>
    </h2>
    

      <footer>
      <article typeof="schema:Person" about="/user/582">
  </article>

      <div>
        Submitted by <span><a title="View user profile." href="/user/582" lang="" about="/user/582" typeof="schema:Person" property="schema:name" datatype="">matt</a></span>
 on <span>Wed, 11/01/2017</span>
        
      </div>
    </footer>
  
  <div>
    
            <div><p>Since the early 2000s cardiac biomarkers have become the cornerstone for diagnosis, risk stratification and therapeutic decision in cardiovascular diseases, specifically NT-proBNP (congestive heart failure) and cardiac troponins (acute coronary syndromes).</p></div>
      
  <div>
    <div>Link</div>
              <div><a href="http://www.scorgloballifeamericas.com/en-us/knowledgecenter/nt-probnp-screening-marker-underwriting">Demystifying NT-proBNP as a Screening Marker for Underwriting Purposes </a></div>
          </div>

      <div>
              <div><a href="/taxonomy/term/43" hreflang="en">NT-proBNP</a></div>
              <div><a href="/taxonomy/term/333" hreflang="en">biomarkers</a></div>
              <div><a href="/taxonomy/term/99" hreflang="en">coronary artery disease (CAD)</a></div>
          </div>
  
  </div>

</article>
</div>
    <div class="views-row"><article data-history-node-id="25842" role="article" about="/insureintell-1col/node/25842">

  
      <h2>
      <a href="/insureintell-1col/node/25842" rel="bookmark"><span>Underwriting Presentations from the Spring 2017 WAHLU Meeting</span>
</a>
    </h2>
    

      <footer>
      <article typeof="schema:Person" about="/user/582">
  </article>

      <div>
        Submitted by <span><a title="View user profile." href="/insureintell-1col/user/582" lang="" about="/insureintell-1col/user/582" typeof="schema:Person" property="schema:name" datatype="">matt</a></span>
 on <span>Thu, 05/18/2017</span>
        
      </div>
    </footer>
  
  <div>
    
            <div><p>The following presentations from the April 27, 2017 Wisconsin Association of Health and Life Underwriters Meeting have been posted at the WAHLU site:</p>

<ul>
	<li>Underwriting around the World by Al Klein</li>
	<li>Autoimmune Disease: Triggers and Treatments by Anne Sherman</li>
	<li>NT-proBNP and Some Other Stuff by Hank George</li>
</ul></div>
      
  <div>
    <div>Link</div>
              <div><a href="http://www.wahlu.org/presentations/">http://www.wahlu.org/presentations/</a></div>
          </div>

      <div>
              <div><a href="/insureintell-1col/taxonomy/term/444" hreflang="en">autoimmune disease</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/43" hreflang="en">NT-proBNP</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/48" hreflang="en">Global Industry</a></div>
          </div>
  
  </div>

</article>
</div>
    <div class="views-row"><article data-history-node-id="25231" role="article" about="/insureintell-1col/node/25231">

  
      <h2>
      <a href="/insureintell-1col/node/25231" rel="bookmark"><span>NT-pro BNP in Risk Assessment of those having Stable Coronary Atherosclerotic Heart Disease (CAD)</span>
</a>
    </h2>
    

      <footer>
      <article typeof="schema:Person" about="/user/582">
  </article>

      <div>
        Submitted by <span><a title="View user profile." href="/insureintell-1col/user/582" lang="" about="/insureintell-1col/user/582" typeof="schema:Person" property="schema:name" datatype="">matt</a></span>
 on <span>Mon, 10/31/2016</span>
        
      </div>
    </footer>
  
  <div>
    
            <div><p>N Terminal-pro Brain Natriuretic Peptide (NT-pro BNP) is produced by cardiac muscle cells (myocytes) in response to cardiac wall stress and myocardial ischemia. NT-pro BNP has been shown to predict all-cause mortality in insurance applicants without a history of heart disease, as well as in the general population. It has been found to improve future cardiovascular risk estimation when considered along with classic cardiovascular risk assessors. It has also been identified as an indicator of future mortality risk in those having stable coronary atherosclerotic heart disease (CAD)</p>
<p><a href="https://www.munichre.com/site/marclife-mobile/get/documents_E-1601107471/marclife/assset.marclife/Documents/Publications/NT-pro-BN-Stable-CAD_WP_10-21-16.pdf" title="https://www.munichre.com/site/marclife-mobile/get/documents_E-1601107471/marclife/assset.marclife/Documents/Publications/NT-pro-BN-Stable-CAD_WP_10-21-16.pdf">https://www.munichre.com/site/marclife-mobile/get/documents_E-1601107471...</a></p>
</div>
      
      <div>
              <div><a href="/insureintell-1col/taxonomy/term/99" hreflang="en">coronary artery disease (CAD)</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/43" hreflang="en">NT-proBNP</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/68" hreflang="en">Risk Management (General)</a></div>
          </div>
  
  </div>

</article>
</div>
    <div class="views-row"><article data-history-node-id="25270" role="article" about="/insureintell-1col/node/25270">

  
      <h2>
      <a href="/insureintell-1col/node/25270" rel="bookmark"><span>NT-proBNP and Life Insurance Underwriting</span>
</a>
    </h2>
    

      <footer>
      <article typeof="schema:Person" about="/user/582">
  </article>

      <div>
        Submitted by <span><a title="View user profile." href="/insureintell-1col/user/582" lang="" about="/insureintell-1col/user/582" typeof="schema:Person" property="schema:name" datatype="">matt</a></span>
 on <span>Tue, 08/09/2016</span>
        
      </div>
    </footer>
  
  <div>
    
            <div><p>Sometimes when we introduce a new requirement or get challenged by an agent or broker about the use of a test, it’s helpful to have a generic document to explain in simple terms what it is and why we use it.</p>
<p>We were recently asked by an insurer to write a short piece for producer consumption on NT-proBNP. They were on the cusp of replacing ECGs with NT-proBNP and wanted an efficient way of explaining their decision as well as telling their producers what<br />
NT-proBNP.</p>
<p>This is what we came up with.</p>
<p>If this is of any value to you, please feel free to use it.</p>
<p>If you decide to leave it unedited, you can leave my name and short bio on it to potentially increase its credibility a tad.</p>
<p>On the other hand, if you decide to modify it, go for it…but please leave off my name and bio if you choose this option.</p>
<p>Cheers,</p>
<p>Hank</p>
<table id="attachments" class="sticky-enabled">
 <thead><tr><th>Attachment</th><th>Size</th> </tr></thead>
<tbody>
 <tr class="odd"><td><a href="http://www.insureintell.com/sites/default/files/NT-proBNP_And_LifeInsuranceUnderwriting.pdf">NT-proBNP_And_LifeInsuranceUnderwriting.pdf</a></td><td>112.32 KB</td> </tr>
</tbody>
</table>
</div>
      
      <div>
              <div><a href="/insureintell-1col/taxonomy/term/43" hreflang="en">NT-proBNP</a></div>
          </div>
  
  </div>

</article>
</div>
    <div class="views-row"><article data-history-node-id="25362" role="article" about="/insureintell-1col/node/25362">

  
      <h2>
      <a href="/insureintell-1col/node/25362" rel="bookmark"><span>Critical Implications of NT-pro BNP in Underwriting Type 2 Diabetics</span>
</a>
    </h2>
    

      <footer>
      <article typeof="schema:Person" about="/user/582">
  </article>

      <div>
        Submitted by <span><a title="View user profile." href="/insureintell-1col/user/582" lang="" about="/insureintell-1col/user/582" typeof="schema:Person" property="schema:name" datatype="">matt</a></span>
 on <span>Fri, 02/26/2016</span>
        
      </div>
    </footer>
  
  <div>
    
            <div><p>N Terminal-pro Brain Natriuretic Peptide (NT-pro BNP) is produced by cardiac muscle cells (myocytes) in response to cardiac wall stress and to ischemia as well.</p>
<p><a href="http://www.munichre.com/site/marclife-mobile/get/documents_E2080099610/marclife/assset.marclife/Documents/Publications/NT-pro-BNP-Lund-WP_onlineFINAL.pdf" title="http://www.munichre.com/site/marclife-mobile/get/documents_E2080099610/marclife/assset.marclife/Documents/Publications/NT-pro-BNP-Lund-WP_onlineFINAL.pdf">http://www.munichre.com/site/marclife-mobile/get/documents_E2080099610/m...</a></p>
</div>
      
      <div>
              <div><a href="/insureintell-1col/taxonomy/term/43" hreflang="en">NT-proBNP</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/236" hreflang="en">type 2 diabetes</a></div>
          </div>
  
  </div>

</article>
</div>
    <div class="views-row"><article data-history-node-id="25383" role="article" about="/insureintell-1col/node/25383">

  
      <h2>
      <a href="/insureintell-1col/node/25383" rel="bookmark"><span>Clinical Implications of NT-proBNP in Underwriting Type 2 Diabetics</span>
</a>
    </h2>
    

      <footer>
      <article typeof="schema:Person" about="/user/582">
  </article>

      <div>
        Submitted by <span><a title="View user profile." href="/insureintell-1col/user/582" lang="" about="/insureintell-1col/user/582" typeof="schema:Person" property="schema:name" datatype="">matt</a></span>
 on <span>Sun, 01/03/2016</span>
        
      </div>
    </footer>
  
  <div>
    
            <div><p>N Terminal-pro Brain Natriuretic Peptide (NT-pro BNP) is produced by cardiac muscle cells (myocytes) in response to cardiac wall stress and to ischemia as well. NT-pro BNP has been shown to predict all-cause mortality in individuals without history of heart disease. This has been found in both insurance and general populations. It has also been found to improve future cardiovascular risk estimation when considered along with classic cardiovascular risk assessors.</p>

<p><a href="http://www.munichre.com/site/marclife-mobile/get/documents_E771093465/marclife/assset.marclife/Documents/Press%20%26%20News/Thought%20Leadership/NT-pro-BNP-Lund-WP_onlineFINAL.pdf">http://www.munichre.com/site/marclife-mobile/get/documents_E771093465/marclife/assset.marclife/Documents/Press%20%26%20News/Thought%20Leadership/NT-pro-BNP-Lund-WP_onlineFINAL.pdf</a></p>
</div>
      
  <div>
    <div>Link</div>
              <div><a href="http://www.munichre.com/site/marclife-mobile/get/documents_E771093465/marclife/assset.marclife/Documents/Press%20%26%20News/Thought%20Leadership/NT-pro-BNP-Lund-WP_onlineFINAL.pdf">munichre.com</a></div>
          </div>

      <div>
              <div><a href="/insureintell-1col/taxonomy/term/50" hreflang="en">mortality</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/43" hreflang="en">NT-proBNP</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/236" hreflang="en">type 2 diabetes</a></div>
          </div>
  
  </div>

</article>
</div>
    <div class="views-row">


<div data-history-node-id="25804" class="node node--type-article node--view-mode-teaser-alt ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/insureintell-1col/node/25804" hreflang="en">NT-proBNP: Implications for Life and Morbidity Risk Underwriting</a>
</h2>
</div>
      
            <div>Sun, 03/09/2014</div>
      
            <div property="schema:text">This paper is the third comprehensive literature review on the cardiac marker NT-proBNP.

This new paper is based on 577 studies, reviews and commentaries published in the global medical literature between mid-2009 and March 2014.
It documents the length and breadth of the burgeoning evidence of NT-proBNP’s value as a screening and re exive test in life insurance underwriting.

Together with the NT-proBNP mortality study by Clark et al, this paper should put to rest any lingering questions or reservations in this regard.
</div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div><h3>
  <a href="/insureintell-1col/node/25804" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/insureintell-1col/taxonomy/term/43" property="schema:about" hreflang="en">NT-proBNP</a></div>
              <div property="schema:about"><a href="/insureintell-1col/taxonomy/term/231" property="schema:about" hreflang="en">morbidity</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/433" property="schema:about" hreflang="en">risk</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25714" class="node node--type-article node--view-mode-teaser-alt ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/insureintell-1col/node/25714" hreflang="en">Underwriting with NT-proBNP (Slides)</a>
</h2>
</div>
      
            <div>Wed, 05/22/2013</div>
      
            <div property="schema:text"><p>Slides from Hank's presentation at the Critical Issues in Medical Underwriting Seminar held May 7 at the Chicago O'Hare Sheraton Four Points Hotel.</p></div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div><h3>
  <a href="/insureintell-1col/node/25714" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/insureintell-1col/taxonomy/term/43" property="schema:about" hreflang="en">NT-proBNP</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25715" class="node node--type-article node--view-mode-teaser-alt ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/insureintell-1col/node/25715" hreflang="en">Report  of  an  NT-­proBNP  Survey  of  Reinsurers</a>
</h2>
</div>
      
            <div>Wed, 04/24/2013</div>
      
            <div property="schema:text"><p>We surveyed U.S. reinsurers regarding their practices and viewpoints<br />
about use of the NT-proBNP cardiac test by their clients. The report of this survey will be of keen interest to insurers using (or contemplating the use of) NT-proBNP.</p></div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div><h3>
  <a href="/insureintell-1col/node/25715" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/insureintell-1col/taxonomy/term/43" property="schema:about" hreflang="en">NT-proBNP</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/116" property="schema:about" hreflang="en">Reinsurance</a></div>
          </div>
  
  </div>

</div>

</div>
    <div class="views-row">


<div data-history-node-id="25719" class="node node--type-article node--view-mode-teaser-alt ds-2col-stacked-fluid clearfix" typeof="schema:Article">

  

  <div class="group-header">
    
            <div><h2>
  <a href="/insureintell-1col/node/25719" hreflang="en">Underwriting Requirement Practices: Always Consider the Big Picture</a>
</h2>
</div>
      
            <div>Wed, 09/19/2012</div>
      
            <div property="schema:text">
<p>When life insurers set their underwriting requirement practices, the primary focus has always been on protective value (cost vs. benefit). In many smaller companies lacking the resources to conduct internal studies, the usual approach is to consider the practices of larger carriers and most notably those known to routinely do such studies.</p></div>
      
  </div>

  
  
  <div class="group-footer">
    
            <div><h3>
  <a href="/insureintell-1col/node/25719" hreflang="en">Continue..</a>
</h3>
</div>
      
      <div>
              <div><a href="/insureintell-1col/taxonomy/term/391" property="schema:about" hreflang="en">CEA</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/392" property="schema:about" hreflang="en">exercise ECG</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/44" property="schema:about" hreflang="en">marijuana</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/43" property="schema:about" hreflang="en">NT-proBNP</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/393" property="schema:about" hreflang="en">practices</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/131" property="schema:about" hreflang="en">predictive modeling</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/139" property="schema:about" hreflang="en">requirement</a></div>
              <div><a href="/insureintell-1col/taxonomy/term/246" property="schema:about" hreflang="en">testing</a></div>
          </div>
  
  </div>

</div>

</div>

      <nav role="navigation" aria-labelledby="pagination-heading">
    <h4 id="pagination-heading" class="visually-hidden">Pagination</h4>
    <ul class="js-pager__items">
                    <li>
          Page 1        </li>
                    <li>
          <a href="/insureintell-1col/taxonomy/term/43/page/2" title="Go to next page" rel="next">
            <span class="visually-hidden">Next page</span>
            <span aria-hidden="true">››</span>
          </a>
        </li>
          </ul>
  </nav>


  
  

  
  <a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/43/feed" class="feed-icon">
  Subscribe to NT-proBNP
</a>

</div>
</div>

</section>



  </div>

                        </div>
                    </section>
                                            </div>
        </div>
        <div class="clearfix"></div>
        <footer class="site-footer">
            <div class="layout-container">
                                                    <div class="site-footer__bottom container page_footer">
                          <div>
    <div id="block-foot-3" class="block block-block-content block-block-content084078bf-6f39-47ba-bdb3-8d97b34316a4">
    
        
            <div class="content">
            
            <div><footer class="text-align-center">
<h5>Insureintell.com is an independent publication designed to provide business information and opinion to life and health insurance underwriters. It is intended to encourage discussion and further research.<br />
Insureintell.com does not recommend any specific action or risk appraisal in any individual life or health insurance application. All information and opinion published should undergo formal scrutiny by underwriting officers, medical directors, actuaries, legal counsel and other insurance professionals as appropriate.</h5>

<h5>Copyright® 2019&nbsp;Hank George, Inc. All Rights Reserved.</h5>
</footer>
</div>
      
        </div>
    </div>

  </div>

                    </div>
                            </div>
        </footer>
    </div>
</div>
  </div>

<div class="region region-page-bottom"><div id="fancy_login_dim_screen"></div><div id="fancy_login_login_box"><div id="fancy_login_form_contents"><a href="#" id="fancy_login_close_button">X</a><div id="fancy_login_user_login_block_wrapper"><form class="fancy-login-user-login-form" data-drupal-selector="fancy-login-user-login-form" action="/insureintell-1col/taxonomy/term/43?page=0" method="post" id="fancy-login-user-login-form" accept-charset="UTF-8">
  <div class="js-form-item form-item js-form-type-textfield form-item-name js-form-item-name">
      <label for="edit-name" class="js-form-required form-required">Username</label>
        <input autocorrect="none" autocapitalize="none" spellcheck="false" data-drupal-selector="edit-name" type="text" id="edit-name" name="name" value="" size="15" maxlength="60" class="form-text required" required="required" aria-required="true" />

        </div>
<div class="js-form-item form-item js-form-type-password form-item-pass js-form-item-pass">
      <label for="edit-pass" class="js-form-required form-required">Password</label>
        <input data-drupal-selector="edit-pass" type="password" id="edit-pass" name="pass" size="15" maxlength="128" class="form-text required" required="required" aria-required="true" />

        </div>
<input autocomplete="off" data-drupal-selector="form-fspmqp4f8ygd4wzuaujy8lemhawtzlimadsw5eqlvt0" type="hidden" name="form_build_id" value="form-FsPMqp4f8YGd4wZuAUJY8LemHAWTzlimaDSW5eQLVT0" />
<input data-drupal-selector="edit-fancy-login-user-login-form" type="hidden" name="form_id" value="fancy_login_user_login_form" />
<ul data-drupal-selector="edit-user-links"><li><a href="/insureintell-1col/user/password" title="Request new password via email.">Request new password</a></li></ul><div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"><input data-drupal-selector="edit-submit-1592926135" type="submit" id="edit-submit-1592926135" name="op" value="Log in" class="button js-form-submit form-submit" />
</div>

</form>
</div></div></div></div>
<script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/insureintell-1col\/","scriptPath":null,"pathPrefix":"","currentPath":"taxonomy\/term\/43","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","currentQuery":{"page":"0"}},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"core\/drupal.ajax,core\/html5shiv,core\/jquery.form,ds\/ds_2col_stacked_fluid,extlink\/drupal.extlink,fancy_login\/popup,fontyourface\/font_display_light_skeleton,google_analytics\/google_analytics,light_skeleton\/skeleton,system\/base,views\/views.module","theme":"light_skeleton","theme_token":null},"ajaxTrustedUrl":{"form_action_p_pvdeGsVG5zNF_XLGPTvYSKCf43t8qZYSwcfZl2uzM":true,"\/insureintell-1col\/taxonomy\/term\/43?page=0\u0026ajax_form=1":true},"fancyLogin":{"screenFadeColor":"grey","screenFadeZIndex":10,"loginBoxBackgroundColor":"white","loginBoxTextColor":"black","loginBoxBorderColor":"black","loginBoxBorderWidth":"1px","loginBoxBorderStyle":"solid","loginPath":"\/user\/login","dimFadeSpeed":null,"boxFadeSpeed":null,"hideObjects":false},"ajax":{"edit-submit-1592926135":{"callback":"fancy_login_user_login_block_ajax_callback","event":"mousedown","keypress":true,"prevent":"click","url":"\/insureintell-1col\/taxonomy\/term\/43?page=0\u0026ajax_form=1","dialogType":"ajax","submit":{"_triggering_element_name":"op","_triggering_element_value":"Log in"}}},"google_analytics":{"trackOutbound":true,"trackMailto":true,"trackDownload":true,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip"},"data":{"extlink":{"extTarget":true,"extTargetNoOverride":null,"extNofollow":null,"extFollowNoOverride":null,"extClass":"ext","extLabel":"(link is external)","extImgClass":false,"extSubdomains":true,"extExclude":"","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":false,"extAlertText":"","mailtoClass":"0","mailtoLabel":"(link sends email)"}},"user":{"uid":0,"permissionsHash":"9eefd52671687a581488e58f9810121b71f4049b340084fc527a3c9edd844181"}}</script>
<script src="/insureintell-1col/sites/default/files/js/js_e6-SH2JCxM0WNYs4R1vHEs5bWDpCzWT3qWBkLw5LK-Q.js"></script>

</body>
</html>
